Molecular shuttle chelation: the use of ascorbate, desferrioxamine and Feralex-G in combination to remove nuclear bound aluminum.
about
The mobilization of aluminum into the biosphereBeta-Amyloid Precursor Protein (βAPP) Processing in Alzheimer's Disease (AD) and Age-Related Macular Degeneration (AMD)Design of iron chelators with therapeutic application.Selective acetylcholinesterase inhibitor activated by acetylcholinesterase releases an active chelator with neurorescuing and anti-amyloid activitiesAmyloid beta (Aβ) peptide modulators and other current treatment strategies for Alzheimer's disease (AD).Metal-sulfate induced generation of ROS in human brain cells: detection using an isomeric mixture of 5- and 6-carboxy-2',7'-dichlorofluorescein diacetate (carboxy-DCFDA) as a cell permeant tracer.Therapeutic potential of iron chelators in diseases associated with iron mismanagement.microRNA (miRNA) speciation in Alzheimer's disease (AD) cerebrospinal fluid (CSF) and extracellular fluid (ECF)NF-κB-regulated, proinflammatory miRNAs in Alzheimer's disease.Generation of Reactive Oxygen Species (ROS) and Pro-Inflammatory Signaling in Human Brain Cells in Primary Culture.The potential application of iron chelators for the treatment of neurodegenerative diseases.Towards the prevention of potential aluminum toxic effects and an effective treatment for Alzheimer's disease.3-Hydroxypyridinone derivatives as metal-sequestering agents for therapeutic use.Aluminum and its potential contribution to Alzheimer's disease (AD).A new approach to studying ion uptake by actinomycetes.A new approach for potential combined chelation therapy using mono- and bis-hydroxypyridinones.
P2860
Q26864062-191CCA9F-138E-4A9C-9FB0-1573350CCAA3Q27021938-BF0B0F38-56DB-4189-8AE9-A09CEFEE0D2CQ34258805-81230B08-BB2E-4671-AF50-766A8F27A516Q36012323-38A9220C-EE61-46D6-AA1B-D3F2B1B518BFQ36103515-FB1F24D7-118E-43B8-984E-CE626F3A27FEQ36202274-B1253472-AE26-4676-90A6-B49F8C370404Q36461028-BF6690F8-36A6-4BFD-B1A8-161862449187Q36499038-33955339-9564-46EB-B615-18ACED6626B4Q36632979-02349F9C-7188-4A4F-B255-9D697D64DD0BQ37627211-E89629CB-6674-4B3E-8157-2A0D38FBD1ABQ37846107-2BA92987-1CCE-4B53-AA28-F6895BEA8CC3Q37958200-6AA470D6-10CB-43EB-9AF3-04112510D5A3Q38397352-4CDBF046-D233-4E35-95D2-3A2FE223B117Q38752912-D923B7F0-7766-42DC-B28B-F960A4B17029Q44262169-C88F1E73-D3C0-4621-A37C-0029FCB10B48Q46753920-0AA90CDA-4F94-47C7-A38A-45C470338836
P2860
Molecular shuttle chelation: the use of ascorbate, desferrioxamine and Feralex-G in combination to remove nuclear bound aluminum.
description
2004 nî lūn-bûn
@nan
2004 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2004 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
name
Molecular shuttle chelation: t ...... remove nuclear bound aluminum.
@ast
Molecular shuttle chelation: t ...... remove nuclear bound aluminum.
@en
Molecular shuttle chelation: t ...... remove nuclear bound aluminum.
@nl
type
label
Molecular shuttle chelation: t ...... remove nuclear bound aluminum.
@ast
Molecular shuttle chelation: t ...... remove nuclear bound aluminum.
@en
Molecular shuttle chelation: t ...... remove nuclear bound aluminum.
@nl
prefLabel
Molecular shuttle chelation: t ...... remove nuclear bound aluminum.
@ast
Molecular shuttle chelation: t ...... remove nuclear bound aluminum.
@en
Molecular shuttle chelation: t ...... remove nuclear bound aluminum.
@nl
P2093
P1476
Molecular shuttle chelation: t ...... remove nuclear bound aluminum.
@en
P2093
Jian-Guo Cui
Maire E Percy
Theo P Kruck
Walter J Lukiw
P304
P356
10.1023/B:CEMN.0000022773.70722.B2
P577
2004-06-01T00:00:00Z
P6179
1044553476